Log in
Enquire now

List of Antigen Express patents

List of Antigen Express patents
List of Yokogawa Electric patents
List of Bill & Melinda Gates Foundation patents
List of Audiobyte patents
Clinical Studies Sponsored by Viome
List of awards received by Laura Linney
Patents where
Current Assignee
Name
is
‌
Antigen Express
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9289487 II-key/antigenic epitope hybrid peptide vaccines

Patent 9289487 was granted and assigned to Antigen Express on March, 2016 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
9289487
March 22, 2016
‌
US Patent 7179645 Ii-Key/antigenic epitope hybrid peptide vaccines

Patent 7179645 was granted and assigned to Antigen Express on February, 2007 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
7179645
February 20, 2007
‌
US Patent 7205274 Hybrid peptides modulate the immune response

Patent 7205274 was granted and assigned to Antigen Express on April, 2007 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
7205274
April 17, 2007
‌
US Patent 7935350 Ii-key/Her-2/neu hybrid cancer vaccine

Patent 7935350 was granted and assigned to Antigen Express on May, 2011 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
7935350
May 3, 2011
‌
US Patent 8815249 Ii-key/antigenic epitope hybrid peptide vaccines

Patent 8815249 was granted and assigned to Antigen Express on August, 2014 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
8815249
August 26, 2014
‌
US Patent 8748130 Human papillomavirus / Ii-Key hybrids and methods of use

Patent 8748130 was granted and assigned to Antigen Express on June, 2014 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
8748130
June 10, 2014
‌
US Patent 7541334 Hybrid peptides modulate the immune response

Patent 7541334 was granted and assigned to Antigen Express on June, 2009 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
7541334
June 2, 2009
‌
US Patent 8889143 Ii-key/HER-2/neu hybrid cancer vaccine

Patent 8889143 was granted and assigned to Antigen Express on November, 2014 by the United States Patent and Trademark Office.

‌
Antigen Express
United States Patent and Trademark Office
United States Patent and Trademark Office
8889143
November 18, 2014
8 results
0 selected
8 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us